Background: In healthy subjects, Nordic walking (NW) generates higher oxygen uptake (V˙O2) than standard walking at an equal rate of perceived exertion (RPE). The feasibility and positive outcomes of NW in patients with chronic obstructive pulmonary disease (COPD) have been reported. Objectives: The aim of the current study is to assess the physiological responses and RPE during NW in COPD patients. Methods: In 15 COPD patients [mean (SD) age 67 (9) years] with a forced expiratory volume in the 1st s of 55% (15)], V˙O2, minute ventilation and heart rate were measured with a portable system during the 6-min walking test (6MWT), incremental shuttle walking test (SWT), 6-min NW on solid ground (6mNWground) and 6-min NW on soft dry beach sand (6mNWsand). The RPE using a modified Borg scale was assessed after each test. Results: 6mNWground and 6mNWsand showed a higher V˙O2 plateau compared with the 6MWT and peak V˙O2 measured during SWT [mean (SD) V˙O2 21 (3), 22 (4), 18 (4) and 19 (5) ml·kg-1·min-1, respectively; p < 0.05 each]. However, no differences in RPE were observed among 6mNWground, 6MWT and SWT [modified Borg scale score for dyspnea 4.2 (2.0), 4.1 (1.8) and 4.3 (1.7), respectively; nonsignificant]. However, RPE in 6mNWsand was significantly higher than in all the other exercise protocols [modified Borg scale score for dyspnea 5.2 (2.2); p < 0.05]. Conclusions: In COPD patients, the use of Nordic poles generates higher V˙O2 than standard walking with no differences in the dyspnea score. The results indicate the potential to enhance community-based training programs in these patients.

Nordic walking (NW) is a walking modality carried out using special poles with rubber or spike tips resembling Nordic style skiing and constitutes a common outdoor physical activity carried out by healthy people worldwide [1]. Moreover, NW has shown effectiveness as a training method to improve aerobic capacity and quality of life both in healthy subjects and patients with chronic conditions [2], including chronic obstructive pulmonary disease (COPD) [3].

The main purpose of NW is to exercise the upper limb and trunk muscles, which are not activated during standard walking. In healthy subjects, this increase in the exercising muscle mass translates into higher oxygen uptake [4] with equal [5,6] or only slightly higher [7] levels of perceived exertion than during standard walking. However, there is no information on the physiological responses during NW in COPD patients in whom ventilatory limitation to exercise might lead to dynamic hyperinflation and a higher rate of perceived exertion (RPE) [8] that could eventually preclude generalization of the findings reported in healthy subjects [4,5,6,7].

The rationale behind the current study is that a better knowledge of the physiological responses during NW in COPD patients may facilitate the design of exercise training programs based on this modality of exercise. In the current research, we assessed the physiological responses during 6 min of NW on two different surfaces that were chosen because they are easily available in many urban environments: solid ground (6mNWground) and soft dry beach sand (6mNWsand). The measurements were compared with those obtained during both the standard 6-min walking test (6MWT) and the incremental shuttle walking test (SWT).

Study Design

Sixteen clinically stable COPD patients (outpatients from the Hospital Clínic de Barcelona) were recruited from February to March 2010 for this study. Inclusion criteria were: (i) a diagnosis of COPD according to the criteria defined by the Global Initiative for Chronic Obstructive Lung Diseases [9]; (ii) no clinical evidence of major cardiovascular or neuromuscular diseases; (iii) no need for supplementary oxygen during exercise, and (iv) tolerance of the facemask during exercise testing. Of note, 10 of the 15 patients were on combined therapy with a long-acting anticholinergic compound and a long-acting β2-agonist, and the remaining 5 patients on inhaled corticosteroids combined with a long-acting β2-agonist. Moreover, 4 patients were also treated with simvastatin and 5 patients received furosemide for the treatment of hypercholesterolemia and arterial hypertension, respectively. All patients agreed to participate and signed the informed consent approved by the Ethics Committee for Clinical Research at Hospital Clínic de Barcelona.

For all patients, clinical history was obtained and physical examination was performed. Standard measurements included: (i) forced spirometry and static lung volumes (Master-Screen; Jaeger, Würzburg, Germany); (ii) lung single-breath CO transfer capacity (Master-Screen); (iii) arterial blood gases (partial O2 and CO2 pressure in arterial blood) at rest (800 series; Ciba Corning, Medfield, Mass., USA), and (iv) bioelectrical impedance to determine body composition (Quantum X - Bioelectrical Body Composition Analyzer; RJL Systems, Clinton Township, Mich., USA).

Exercise Measurements

All patients became familiar with the NW technique after being coached by a specialized professional. All of them performed four exercise protocols in two different days in random order: (i) incremental SWT [10] to assess peak oxygen uptake (V˙O2); (ii) 6MWT [11]; (iii) 6mNWground, and (iv) 6mNWsand. The two NW tests were performed according to the American Thoracic Society guidelines for 6MWT [11] to ensure comparability among exercise protocols.

During all exercise testing, patients breathed through an adult facemask (Hans Rudolph Inc., Kansas City, Mo., USA; 8940 series, made for Cortex Biophysik GmbH, Leipzig, Germany), which was carefully adjusted to the patient's face and checked for air leaks. The patients were able to move freely without discomfort because of the light weight of the equipment (650 g). The length of the poles (Spin Pole Package; Leki, Buffalo, N.Y., USA) was adjusted for each patient.

During testing, we performed breath-by-breath measurements using a portable system (MetaMax® 3B portable CPX system; Cortex Biophysik), which was calibrated before each test. Moreover, an online telemetric assessment of the quality of data collection was done during the testing. The measured variables during exercise testing were: V˙O2, carbon dioxide production, minute ventilation (V˙E) and heart rate (HR). For both dyspnea and leg discomfort, RPE was assessed immediately after each protocol using a modified Borg scale ranging from 0 to 10 [12].

Statistical Analysis

Results are presented as means (SD), interquartile ranges or n (%) for continuous and categorical variables, respectively. We analyzed the time evolution of the Gaussian continuous variables and compared the four exercise protocols by means of a longitudinal mixed model for repeated measurements taking the intrasubject correlation into account. The characteristics of the slope for the variables V˙O2, V˙E and HR against time for the four exercise protocols were analyzed using a standard regression model. From that model, we assessed whether the slope was within a ±5% tolerability margin from 0 (i.e. flat slope), in order to evaluate the steady-state profile of each variable. A value of p < 0.05 was considered statistically significant.

One of the 16 COPD patients was excluded because of the patient's inability to tolerate the face mask during the exercise protocols. The characteristics of the 15 patients finally assessed are displayed in table 1.

Table 1

Characteristics of the study group (n = 15)

Characteristics of the study group (n = 15)
Characteristics of the study group (n = 15)

Figure 1 depicts the physiological responses throughout each of the four exercise protocols assessed in the study. Of note, the two NW tests and 6MWT showed a V˙O2 plateau from minute 3 of the testing. However, V˙E and HR showed a slow incremental profile throughout the 6-min exercise.

Fig. 1

O2, V˙E and HR responses during the four walking protocols.

Fig. 1

O2, V˙E and HR responses during the four walking protocols.

Close modal

Table 2 displays the physiological measurements expressed as mean values of the last 15 s of each test. Both 6mNWground and 6mNWsand presented similarly higher V˙O2 (ml·kg-1·min-1) than the other two exercise protocols. Briefly, 6mNWgroundO2 was 17 and 11% higher than the values obtained in 6MWT and SWT, respectively (p < 0.05 each), whereas 6mNWsandO2 was 22 and 16% above the measurements obtained during 6MWT and SWT, respectively (p < 0.05 each). As expected, peak V˙O2 (ml·kg-1·min-1) in the SWT was 6% higher than that observed in the 6MWT (p < 0.05). Similar trends were seen for both V˙E and HR (table 2). Of note, however, no differences in V˙E were seen between SWT and 6MWT. Moreover, 6mNWsand HR was significantly higher compared with the other three exercise protocols (7, 11 and 13% for 6mNWground, SWT and 6MWT, respectively; p < 0.05 each) without differences in HR among these three exercise protocols.

Table 2

Physiological responses to the different exercise tests

Physiological responses to the different exercise tests
Physiological responses to the different exercise tests

No differences in dyspnea rating assessed after 6mNWground, 6MWT and SWT were observed (table 2). In contrast, 6mNWsand showed significantly higher dyspnea rating compared with the other three exercise protocols: 21, 24 and 27% for 6MWT, 6mNWground and SWT, respectively (p < 0.05 each). Likewise, leg fatigue rating reported after 6mNWsand was also significantly higher than that reported after 6mNWground (31%; p < 0.05).

Main Findings

To our knowledge, this is the first study exploring the physiological responses to NW in COPD patients. The main findings were that: (1) NW (6mNWground) results in an increase in V˙O2, V˙E and HR levels compared with standard walking (6MWT); (2) V˙O2 levels achieved during the two NW modalities showed a steady-state profile indicating high but sustainable exercise intensity, and (3) the increase in oxygen uptake generated during 6mNWground does not translate into a higher RPE compared with standard walking (6MWT) in these patients.

Contributions Beyond the Existing Knowledge

Previous studies in healthy subjects [4,5,6,7] have reported a systematic increment in V˙O2 levels during NW compared with standard walking, ranging from 7 to 23%. The present investigation showed an increase of 17% in V˙O2 during 6mNWground compared with 6MWT and a parallel increase in V˙E (28%). Moreover, the current study clearly indicates that in patients with moderate-to-severe COPD, as previously reported in healthy subjects [5,6], the increase in V˙O2 during 6mNWground was not accompanied by a parallel increase in RPE. Even more importantly, the V˙O2 profile during the two NW protocols (6minNWground and 6minNWsand) indicated sustainability over time of this exercise modality irrespective of the walking surface. The changes in V˙O2 during NW can be reasonably attributed to the increase in exercising muscle mass. V˙O2 during NW exceeded V˙O2 peak assessed with SWT (table 2). It is well recognized that NW involves recruitment of the upper limb, trunk and lower extremity muscles, whereas standard walking is mostly reduced to lower limb muscle mass.

6mNWsand presented significantly higher both dyspnea and leg discomfort scores than 6mNWground, but V˙E was similar between the two modalities of NW. We hypothesize that the characteristics of the pattern can be explained by different walking ergonomics due to the surface, i.e. higher surface friction and increased difficulty to keep in balance while walking over soft sand should be expected. The lower 6mNWsand walking distance (-33%; p < 0.05) compared with 6mNWground (table 2) supports this interpretation.

Clinical Applicability of the Results

One of the central challenges of pulmonary rehabilitation programs for COPD patients [13] is to provide long-term cost-effective strategies aiming to enhance daily physical activity of these patients [14]. Therefore, NW has been reported to be an effective method to improve both aerobic capacity and physical activity in patients with COPD [3]. The current study reinforces the message by providing novel information on the physiological responses to NW in COPD patients.

We would like to stress the potential of NW as an exercise training method for COPD patients in urban environments, highlighting that NW generates higher intensities than standard walking, but the cardiorespiratory challenge is still sustainable and can be applied to train skeletal muscles. Consequently, we may obtain a higher training stimulus with similar perceived effort. Moreover, for the practice of NW, urban environments provide both an easily accessible and attractive setting as a low-tech, low-cost training approach that may result in enhanced long-term adherence to the program.

Strengths and Limitations

The current results may show limitations for generalization of the main message to very severe COPD patients that were not included in the study because of their inability to support the face mask and, in some cases, the need of long-term oxygen therapy. However, while acknowledging this fact, we would like to stress that patients with moderate/severe disease are the target for this kind of community-based preventive interventions with the aim to improve their health status and, ultimately, to delay disease progression. Finally, the reliability of the results is based on the study design and the quality control procedures, including equipment calibration and telemetric data collection and control during the tests.

The results of the study suggest that NW could be an appropriate walking modality to train patients with moderate to severe COPD because it generates higher exercise intensity at the same RPE compared with standard walking. However, further studies comparing the impact of NW and standard walking on health outcomes in COPD patients with different degrees of COPD severity are needed before NW is included into community-based rehabilitation programs.

The authors would like to thank Ferran Torres [Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Biostatistics and Data Management Platform, Barcelona] for his support in statistical analyses. We also acknowledge the support received from the staff of the Respiratory Diagnostic Center of the Hospital Clínic de Barcelona.

The study was financially supported by NEXES-Supporting Healthier and Independent Living for Chronic Patients and Elderly (UE grant CIP-ICT-PSP-2007-225025); grants from the Fondo de Investigación Sanitaria (FIS PI-061510); Col·legi de Fisioterapeutes de Catalunya R02-2007 and the 2nd Solidary Triathlon organized by the Barcelona city council sports center Can Ricart.

1.
International Nordic Walking Federation. http://inwa-nordicwalking.com/.
2.
Tschentscher M, Niederseer D, Niebauer J: Health benefits of Nordic walking: a systematic review. Am J Prev Med 2013;44:76-84.
3.
Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF, Burghuber OC, Harti S: Nordic walking improves daily physical activities in COPD: a randomized controlled trial. Respir Res 2010;11:112.
4.
Schiffer T, Knicker A, Hoffman U, Harwig B, Hollmann, Struder HK: Physiological responses to Nordic walking, walking and jogging. Eur J Appl Physiol 2006;98:56-61.
5.
Church TS, Earnest CP, Morss GM: Field testing of physiological responses associated with Nordic walking. Res Q Exerc Sport 2002;73:296-300.
6.
Rodgers CD, VanHeest JL, Schachter CL: Energy expenditure during submaximal walking with Exerstriders. Med Sci Sports Exerc 1995;27:607-611.
7.
Porcari JP, Hendrickson TL, Walter PR, Terry L, Walsko G: The physiological responses to walking with and without Power Poles on treadmill exercise. Res Q Exerc Sport 1997;68:161-166.
8.
Lahaije A, van Helvoort H, Dekhuijzen R, Heijdra Y: Can COPD patients who hyperinflate during daily life activities be identified by laboratory tests? Respiration 2013;86:237-242.
9.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
10.
Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-1024.
11.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
12.
Ries AL: Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale and Visual Analog Scale. COPD 2005;2:105-110.
13.
Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF, ATS/ERS Task Force on Pulmonary Rehabilitation: An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-e64.
14.
Hartman JE, Boezen HM, Zuidema MJ, de Greef MH, Ten Hacken NH: Physical activity recommendations in patients with chronic obstructive pulmonary disease. Respiration 2014;88:92-100.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.